The DOI matches its Crossref record, with a small difference in title or year; 46 of the 46 references it cites were found in a registry or an index.
The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
Open accessAbstract
OBJECTIVE: The Diabetes Prevention Program (DPP) is a 27-center randomized clinical trial designed to evaluate the safety and efficacy of interventions that may delay or prevent development of diabetes in people at increased risk for type 2 diabetes. RESEARCH DESIGN AND METHODS: Eligibility requirements were age > or = 25 years, BMI > or = 24 kg/m2 (> or = 22 kg/m2 for Asian-Americans), and impaired glucose tolerance plus a fasting plasma glucose of 5.3-6.9 mmol/l (or < or = 6.9 mmol for American Indians). Randomization of participants into the DPP over 2.7 years ended in June 1999. Baseline data for the three treatment groups--intensive lifestyle modification, standard care plus metformin, and standard care plus placebo--are presented for the 3,234 participants who have been randomized. RESULTS: Of all participants, 55% were Caucasian, 20% were African-American, 16% were Hispanic, 5% were American Indian, and 4% were Asian-American. Their average age at entry was 51 +/- 10.7 years (mean +/- SD), and 67.7% were women. Moreover, 16% were < 40 years of age, and 20% were > or = 60 years of age. Of the women, 48% were postmenopausal. Men and women had similar frequencies of history of hypercholesterolemia (37 and 33%, respectively) or hypertension (29 and 26%, respectively). On the basis of fasting lipid determinations, 54% of men and 40% of women fit National Cholesterol Education Program criteria for abnormal lipid profiles. More men than women were current or former cigarette smokers or had a history of coronary heart disease. Furthermore, 66% of men and 71% of women had a first-degree relative with diabetes. Overall, BMI averaged 34.0 +/- 6.7 kg/m2 at baseline with 57% of the men and 73% of women having a BMI > or = 30 kg/m2. Average fasting plasma glucose (6.0 +/- 0.5 mmol/l) and HbA1c (5.9 +/- 0.5%) in men were comparable with values in women (5.9 +/- 0.4 mmol/l and 5.9 +/- 0.5%, respectively). CONCLUSIONS: The DPP has successfully randomized a large cohort of participants with a wide distribution of age, obesity, and ethnic and racial backgrounds who are at high risk for developing type 2 diabetes. The study will examine the effects of interventions on the development of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysglycemia is strongly associated with the development of overweight status or obesity, as most DM2 patients are overweight or obese (44–46).”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Part of this paper’s reference list could not be split into single entries.
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,171
Eriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Statistical Considerations in the Intent-to-Treat Principle
Lachin, J. M. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00046-5 · Cited by 652
Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641
Balkau, B., Shipley, M. J., Jarrett, R. J., Pyörälà, K., Pyörälä, M., Forhan, A., & Eschwège, É. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.360 · Cited by 597
Epidemiology of Diabetes and Its Vascular Lesions.
(1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-4-733_1 · Cited by 539
The natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413 · cited 1×
“To the extent that younger age is associated with development of type 2 diabetes in populations with a strong genetic predisposition to type 2 diabetes (5,10), it is notable that the average ages of participants in those groups were lower than among Caucasian participants.”
BackgroundHaffner, S. M., D, M. P. S. M., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diab.39.3.283 · Cited by 397
Haffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diabetes.39.3.283 · Cited by 397
Enzymatic methods for quantification of lipoprotein lipids
Warnick, G. R. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)29064-3 · Cited by 393
Eriksson, J., Lindström, J., Valle, T., Aunola, S., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Lauhkonen, M., Lehto, P., et al. (1999) · Diabetologia · doi:10.1007/s001250051229 · Cited by 368
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosáka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 315
Minnesota Code Manual of Electrocardiographic Findings
Marty, A. T. (1983) · Critical Care Medicine · doi:10.1097/00003246-198307000-00029 · Cited by 311
Sartor, G., Scherstén, B., Carlström, S., Melander, A., Nordén, Å., & Persson, G. (1980) · Diabetes · doi:10.2337/diab.29.1.41 · Cited by 285
The ten-year follow-up of the Bedford Survey (1962?1972): Glucose tolerance and diabetes
KEEN, H., Jarrett, R. J., & McCartney, P. (1982) · Diabetologia · doi:10.1007/bf00254832 · Cited by 282
Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr
Sicree, R. A., Zimmet, P., King, H. O. M., & Coventry, J. S. (1987) · Diabetes · doi:10.2337/diab.36.2.179 · Cited by 232
Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective
Donahue, R. P., & Orchard, T. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.9.1141 · Cited by 230
Worsening to diabetes in men with impaired glucose tolerance (?borderline diabetes?)
Jarrett, R. J., KEEN, H., Fuller, J., & McCartney, M. (1979) · Diabetologia · doi:10.1007/bf00423146 · Cited by 201
Yudkin, J. S., Alberti, K. G. M. M., McLarty, D. G., & Swai, A. B. M. (1990) · BMJ · doi:10.1136/bmj.301.6749.397 · Cited by 191
High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men
Balkau, B., Shipley, M. J., Jarrett, R. J., Pyörälà, K., Pyörälä, M., Forhan, A., & Eschwège, É. (1998) · Diabetes Care · Cited by 186
Chiasson, J.-L., Gomis, R., Hanefeld, M., Josse, R. G., Karasik, A., Laakso, M., & The Stop-Niddm Trial Research Group (1998) · Diabetes Care · doi:10.2337/diacare.21.10.1720 · Cited by 182
Rautaharju, P. M., MacInnis, P. J., Warren, J. W., Hk, W., Rykers, P. M., & Calhoun, H. P. (1990) · Methods of Information in Medicine · doi:10.1055/s-0038-1634798 · Cited by 172
Biological Variation of Glycated Hemoglobin: Implications for diabetes screening and monitoring
Kilpatrick, E. S., Maylor, P. W., & Keevil, B. G. (1998) · Diabetes Care · doi:10.2337/diacare.21.2.261 · Cited by 135
Peterson, J. I., & Young, D. S. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90361-8 · Cited by 133
EPIDEMIOLOGY, OBESITY, AND NON-INSULIN-DEPENDENT DIABETES MELLITUS
Barrett-Connor, E. L. (1989) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036035 · Cited by 104
EPIDEMIOLOGY AND PUBLIC HEALTH ASPECTS OF NON-INSULIN-DEPENDENT DIABETES MELLITUS
Jarrett, R. J. (1989) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036034 · Cited by 100
Little, R. R., England, J. D., Wiedmeyer, H.-M., McKenzie, E. M., Pettitt, D. J., Knowler, W. C., & Goldstein, D. E. (1988) · Diabetes · doi:10.2337/diab.37.1.60 · Cited by 90
Sartor, G., Scherstén, B., Carlström, S., et al. (1980) · Diabetes · doi:10.2337/diabetes.29.1.41 · Cited by 87
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies
Rautaharju, P. M., Calhoun, H. P., & CHAITMAN, B. R. (1991) · Journal of Electrocardiology · doi:10.1016/s0022-0736(10)80041-x · Cited by 85
An automated "high-pressure" liquid-chromatographic assay for hemoglobin A1c.
Ellis, G., Diamandis, E. P., Giesbrecht, E., Daneman, D., & Allen, L. C. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.11.1746 · Cited by 79
King, H., Zimmet, P., Raper, L., & Balkau, B. (1984) · Diabetologia · doi:10.1007/bf00252261 · Cited by 79
Glucose tolerance and mortality, including a substudy of tolbutamide treatment
Knowler, W. C., Sartor, G., Melander, A., & Scherstén, B. (1997) · Diabetologia · doi:10.1007/s001250050734 · Cited by 58
Transient impaired glucose tolerance in Pima Indians: is it important?
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., & Bennett, P. H. (1988) · BMJ · doi:10.1136/bmj.297.6661.1438 · Cited by 48
Eriksson, K.-F., Saltin, B., & Lindgärde, F. (1994) · Diabetes · doi:10.2337/diab.43.6.805 · Cited by 44
Fatness, fat distribution, and glucose tolerance in second-generation Japanese-American (Nisei) men
Newell‐Morris, L. L., Treder, R., Shuman, W. P., & Fujimoto, W. Y. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/50.1.9 · Cited by 31
Background and recruitment data for the U.S. Diabetes Prevention Program.
Fujimoto, W. Y. (2000) · PubMed · Cited by 28
Reproducibility of HbA1c in a healthy adult population: the Telecom Study.
Simon, D., Senan, C., Balkau, B., Saint-Paul, M., Thibult, N., & Eschwège, É. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1361 · Cited by 16
Stability Over Time of Modern Diagnostic Criteria for Type II Diabetes
D, M. P. S. M., Valdez, R. A., Haffner, S. M., Mitchell, B. D., & Hazuda, H. P. (1993) · Diabetes Care · doi:10.2337/diacare.16.7.978 · Cited by 7
Marrero, D. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-39903-0_1199 · Cited by 2
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7
Research works printed but not linked: 1
- [32]32. Hainline A Jr, Karon J, Lippel K (Eds.): Manual of Laboratory Operations. 2nd ed. Lipid Research Clinics Program, Lipid and Lipoprotein Analysis, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health (updated 1983)
Cited by
Sorted by citations
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166
The Diabetes Prevention Program (DPP)
The Diabetes Prevention Program (DPP) Research Group (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2165 · Cited by 1,938
Effect of weight loss with lifestyle intervention on risk of diabetes
Hamman, R. F., Wing, R. R., Edelstein, S. L., Lachin, J. M., Bray, G. A., Delahanty, L., Hoskin, M., Kriska, A. M., Mayer-Davis, E. J., Pi-Sunyer, X., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0560 · Cited by 1,344
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Metadata
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2000-11-01
- Volume
- 23
- Issue
- 11
- Pages
- 1619-1629
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC1360735
- OpenAlex
- W1935237410
- Cited by
- 399
- References
- 44
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 19 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 18 · 2016: 16 · 2015: 16 · 2014: 17 · 2013: 17 · 2012: 22
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Diabetes Association
- Bristol-Myers Squibb
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK048489)
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes prevention, impaired glucose tolerance, prediabetes, metformin, lifestyle modification, baseline characteristics, sex differences, racial and ethnic differences, body mass index, fasting blood glucose, HbA1c, hypercholesterolemia, hypertension, smoking, coronary artery disease, Diabetes Prevention Program
- MeSH terms
- Adult, Asian, Black or African American, Blood Glucose, Blood Pressure, Cholesterol, Coronary Disease, Diabetes Mellitus, Type 2, Female, Hispanic or Latino, Humans, Hypercholesterolemia, Indians, North American, Lipids, Male, Middle Aged, Patient Education as Topic, Risk Factors, Sex Factors, Smoking, Socioeconomic Factors, United States, Cohort Studies, Body Mass Index, Glucose Intolerance, White People, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review